Zimmer Biomet Holdings (ZBH) Share-based Compensation (2009 - 2026)

Zimmer Biomet Holdings has reported Share-based Compensation for 18 years, with the latest figure at $24.2 million in Q1 2026.

• For the quarter ending Q1 2026, Share-based Compensation rose 23.47% year-over-year to $24.2 million; the trailing twelve-month figure through Mar 2026 stood at $117.0 million (up 27.73% YoY), and the FY2025 full-year result was $90.2 million, down 10.69% from the prior year.
• Share-based Compensation for Q1 2026 stood at $24.2 million, roughly flat from $24.1 million in the prior quarter.
• The five-year high for Share-based Compensation was $43.4 million in Q2 2025, with the low at $15.6 million in Q3 2023.
• Average Share-based Compensation over 5 years is $26.0 million, with a median of $25.3 million recorded in 2025.
• Year-over-year, Share-based Compensation jumped 79.87% in 2022 and slumped 43.07% in 2023.
• Tracing ZBH's Share-based Compensation over 5 years: stood at $26.8 million in 2022, then declined by 5.6% to $25.3 million in 2023, then slipped by 16.6% to $21.1 million in 2024, then climbed by 14.22% to $24.1 million in 2025, then advanced by 0.41% to $24.2 million in 2026.
• The last three Share-based Compensation figures came in at $24.2 million (Q1 2026), $24.1 million (Q4 2025), and $25.3 million (Q3 2025), per Business Quant data.

Peer Comparison